Vancouver, Canada

Ian Reid Alexander Mackenzie


 

Average Co-Inventor Count = 12.0

ph-index = 2

Forward Citations = 24(Granted Patents)


Company Filing History:


Years Active: 2013-2016

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Ian Reid Alexander Mackenzie: Innovator in Dementia Detection and Treatment

Introduction

Ian Reid Alexander Mackenzie is a notable inventor based in Vancouver, Canada. He has made significant contributions to the field of neurodegenerative disorders, particularly in the detection and treatment of dementia. With a total of 2 patents, his work focuses on innovative methods that can potentially improve the lives of those affected by dementia.

Latest Patents

Mackenzie's latest patents revolve around detecting and treating dementia. These documents detail methods and materials for identifying mutations linked to dementia, specifically through the detection of one or more mutations within PGRN nucleic acid. Additionally, they provide techniques for measuring the level of progranulin expression. His patents also include methods for treating mammals with neurodegenerative disorders by increasing PGRN polypeptide levels and identifying agents that can facilitate this increase.

Career Highlights

Throughout his career, Mackenzie has worked with esteemed organizations such as the Mayo Foundation for Medical Education and Research and Vib Vzw. His experience in these institutions has allowed him to collaborate with leading experts in the field, further enhancing his contributions to dementia research.

Collaborations

Some of his notable coworkers include Michael L. Hutton and Matthew Charles Baker. Their collaborative efforts have likely played a role in advancing the research and development of innovative solutions for dementia.

Conclusion

Ian Reid Alexander Mackenzie stands out as a dedicated inventor whose work in dementia detection and treatment holds promise for future advancements in neurodegenerative disorder management. His contributions are vital in the ongoing quest to improve the quality of life for those affected by dementia.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…